Article
Author(s):
Scientists from the University of Rostock in Germany explored the range of multiple sclerosis treatment options and examined them for possible infectious outcomes, side effects, and potential fatalities.
Scientists from the University of Rostock Department of Neurology in Germany reviewed existing multiple sclerosis (MS) treatment drugs in a study published in Clinical & Experimental Immunology. The investigators’ conclusions revealed:
“With an increasing number of modern compounds, more potent MS treatment options are available,” the authors wrote.“However, increased efficacy seems to accompany a new and more specific spectrum of side effects, including infectious aspects.” The authors note that this is maybe because of the specific mechanisms of action, but also could be due to closer monitoring of these side effects.